Success Stories: NAILG Helped Cancer Immunotherapy Researcher Win NIW for High-Impact Research in Tumor Treatment

Posted by wegreened on January 30, 2026 in Immunotherapy, NIW

Client’s Testimonial:

“I had a great experience working with NAILG on my NIW case. They understood the scientific details of my work and built a strong, well-organized petition. The process was smooth, and their team was always responsive and helpful. I’d definitely recommend them to other researchers.”

On April 19^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Cancer Immunotherapy (Approval Notice).

General Field: Cancer Immunotherapy

Position at the Time of Case Filing: Postdoctoral Researcher

Country of Origin: Iran

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: April 19^th, 2025

Processing Time: 4 months, 6 days

Case Summary:

Each year, millions of patients in the United States face the burden of solid tumors, often treated with toxic and expensive therapies that come with limited efficacy and significant side effects. The urgent need for safer, more cost-effective, and accessible cancer treatments has never been greater. It is within this context that our client’s work stands out. As an expert in cancer immunotherapy, he is pioneering a new approach: the development of synergistic combination therapies that merge genetic engineering of viruses and immune cells to transform how cancer is treated.

His research focuses on enhancing therapeutic precision while reducing toxicity, treatment costs, and overall patient burden. By integrating engineered immune cells with viral vectors, his work promises more efficient tumor targeting with fewer side effects, redefining what is possible in immuno-oncology. These therapies are designed not only to improve survival outcomes but to make state-of-the-art cancer care more broadly accessible. The implications of this research extend far beyond the lab, supporting national healthcare goals that prioritize scalable, effective solutions for complex diseases.

Throughout his academic career, he has built a strong record of scientific contributions, having authored 18 peer-reviewed journal articles, including 7 as first author, as well as a first-authored conference abstract. His work has been cited 304 times, reflecting its recognition and influence within the scientific and medical research communities.

Recognizing both the impact and national importance of his work, the North America Immigration Law Group (NAILG) collaborated with our client to present a compelling National Interest Waiver (NIW) petition. The legal strategy emphasized the broader health and economic benefits of his research and demonstrated how his continued presence in the United States supports cutting-edge innovation in oncology. USCIS approved the petition, affirming that his research serves a clear national interest and meets the high bar of the NIW framework.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%